<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04255927</url>
  </required_header>
  <id_info>
    <org_study_id>PR2019-26</org_study_id>
    <nct_id>NCT04255927</nct_id>
  </id_info>
  <brief_title>Triclosan-antibacterial Sutures Impact on the Incidence of Surgical Site Infection in Clean-wounds</brief_title>
  <official_title>Triclosan-antibacterial Sutures Impact on the Incidence of Surgical Site Infection in Clean-wounds; Multi-center, Double-blind, Randomized Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>ClinAmygate</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Misr University for Science and Technology</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Al Safwa Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Fayoum University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>ClinAmygate</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Comparing the incidence of PSI in cases using coated Polyglactin 910 suture with Triclosan
      and cases using Polyglactin 910 suture without Triclosan in clean-wound surgery
      (laparoscopic).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this prospective study, we will determine the incidence of PSI in Egypt as well as the
      impact of using coated polyglactin 910 sutures with Triclosan in lowering the incidence of
      PSI in clean-wound surgeries.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 5, 2020</start_date>
  <completion_date type="Anticipated">September 10, 2020</completion_date>
  <primary_completion_date type="Anticipated">August 10, 2020</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>randomized-controlled</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>port site infection (PSI)</measure>
    <time_frame>30 days</time_frame>
    <description>the incidence of port site infection (PSI)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>hospital stay</measure>
    <time_frame>30 days</time_frame>
    <description>Post-operative hospital stay in days</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">274</enrollment>
  <condition>Laparoscopic Surgery</condition>
  <condition>Surgical Wound</condition>
  <condition>Surgical Site Infection</condition>
  <arm_group>
    <arm_group_label>Coated Polyglactin 910 with Triclosan</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Coated Polyglactin 910 with Triclosan</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Coated Polyglactin 910 without Triclosan</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Coated Polyglactin 910 without Triclosan</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Coated Vicryl plus</intervention_name>
    <description>Vicryl plus (Coated Polyglactin 910 with Triclosan)</description>
    <arm_group_label>Coated Polyglactin 910 with Triclosan</arm_group_label>
    <other_name>Coated Polyglactin 910 with Triclosan</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Coated vicryl</intervention_name>
    <description>Vicryl (Coated Polyglactin 910 without Triclosan)</description>
    <arm_group_label>Coated Polyglactin 910 without Triclosan</arm_group_label>
    <other_name>Coated Polyglactin 910 without Triclosan</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age 18-75

          -  candidate for laparoscopic surgical intervention during the period of the study were
             included.

        Exclusion Criteria:

          -  Patient has immunodeficiency disorder.

          -  Patient receiving anti-cancer / immunosuppressive therapy.

          -  Patients with established pre-operative infection whether community acquired or
             hospital acquired either at / remote from the operative site.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Emad R Issak, Diploma</last_name>
    <role>Study Director</role>
    <affiliation>ClinAmygate</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Emad R Issak, Diploma</last_name>
    <phone>00201272228989</phone>
    <email>dr.emad.r.h.issak@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Misr Univeristy for Science and Technology Hospital</name>
      <address>
        <city>Giza</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Moatasem-Bellah A Erfaan, MD</last_name>
      <phone>01223478555</phone>
      <email>mustmedicine@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <results_reference>
    <citation>Ahmed I, Boulton AJ, Rizvi S, Carlos W, Dickenson E, Smith NA, Reed M. The use of triclosan-coated sutures to prevent surgical site infections: a systematic review and meta-analysis of the literature. BMJ Open. 2019 Sep 3;9(9):e029727. doi: 10.1136/bmjopen-2019-029727.</citation>
    <PMID>31481559</PMID>
  </results_reference>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>February 3, 2020</study_first_submitted>
  <study_first_submitted_qc>February 4, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 5, 2020</study_first_posted>
  <last_update_submitted>July 19, 2020</last_update_submitted>
  <last_update_submitted_qc>July 19, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 21, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Surgical Wound Infection</mesh_term>
    <mesh_term>Surgical Wound</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Triclosan</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

